Jane Wasman

Ms. Jane Wasman is an Independent Director at Rigel Pharmaceuticals, Inc., a Chairman at Sellas Life Sciences Group Ltd. and an Independent Director at SELLAS Life Sciences Group, Inc. She is on the Board of Directors at Rigel Pharmaceuticals, Inc. and SELLAS Life Sciences Group, Inc. Ms. Wasman was previously employed as a Chairman by Athersys, Inc., a Chairman by SELLAS Life Sciences Group, Inc. /Old/, a President, Secretary & General Counsel by Acorda Therapeutics Ltd., a Secretary & President-International by Acorda Therapeutics, Inc., a Staff Vice President & Associate General Counsel by Schering-Plough Corp., and an Associate General Counsel-Veteran Affairs by United States Senate.
She also served on the board at Cytovia Therapeutics, Inc., Biotie Therapies Oy and New York Biotechnology Association, Inc. She received her undergraduate degree from Princeton University and a graduate degree from Harvard Law School.